HomeOCUP • NASDAQ
add
Ocuphire Pharma Inc
Previous close
$1.69
Day range
$1.70 - $1.85
Year range
$1.50 - $4.58
Market cap
46.27M USD
Avg Volume
197.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.71M | -2.17% |
Operating expense | 9.42M | 312.21% |
Net income | -7.11M | -22.71% |
Net profit margin | -415.31 | -25.43% |
Earnings per share | -0.29 | -3.57% |
EBITDA | -7.71M | -25.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 47.17M | 20.91% |
Total assets | 51.84M | 14.18% |
Total liabilities | 5.79M | 39.31% |
Total equity | 46.06M | — |
Shares outstanding | 25.09M | — |
Price to book | 0.92 | — |
Return on assets | -36.43% | — |
Return on capital | -40.16% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -7.11M | -22.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2018
Headquarters
Website
Employees
14